Results for: screening

Virulent: The Vaccine War

Virulent: The Vaccine War virtual screening

More tidbits from Virulent: The Vaccine War. Have you purchased your virtual ticket to stream it and be part of the Q&A with the filmmakers hosted by Drs. Gorski and Novella on Jan. 29?

/ January 21, 2023
Virulent: The Vaccine War

Announcing a virtual screening and Q&A for Virulent: The Vaccine War.

SBM has teamed with director/producer Tjardus Greidanus and producer Laura Davis to host a virtual screening of their documentary Virulent: The Vaccine War, followed by a virtual Q&A. We also all thought it appropriate to dedicate the showing of this excellent documentary about vaccine hesitancy and the antivaccine movement to our recently departed colleague, Dr. Harriet Hall.

/ January 19, 2023

COVID-19 vaccination and screening mammography

Reports of enlarged lymph nodes under the arm after COVID-19 vaccination have led doctors to tweak mammography guidelines. Antivaxxers, unsurprisingly, have tried to weaponize this observation to spread fear and confusion about these vaccines.

/ March 22, 2021

Melanoma: A Pseudoepidemic of Skin Cancer Prompts New Screening Recommendations

There appeared to be an epidemic of melanoma skin cancer, but it seems to be a pseudoepidemic caused by overdiagnosis. Screening everyone with skin exams does more harm than good and can no longer be recommended.

/ February 2, 2021
Example of trisomy

Prenatal Screening Tests for Chromosome Abnormalities

Science has made remarkable advances in prenatal screening, but false positives and false negative results can occur, and there are ethical concerns.

/ May 12, 2020

Thermography is Not Approved for Breast Cancer Screening in Canada

Breast cancer thermography is being promoted across Canada as a reliable and effective way of identifying breast tumors. There is no evidence thermography is actually capable of doing so.

/ October 12, 2018

PSA Screening for Prostate Cancer

PSA testing is controversial. A new study finds that PSA screening for prostate cancer offers no survival benefits.

/ March 22, 2018

The ROCA Screening Test for Ovarian Cancer: Not Ready for Prime Time

Ovarian cancer is relatively rare but deadly. The lifetime risk of ovarian cancer is 1.5% compared to 12% for breast cancer, but it is the 5th most common cause of cancer death for women. Since the ovaries are hidden deep in the pelvis and the symptoms of ovarian cancer are non-specific, the cancer is often advanced by the time it is diagnosed...

/ June 21, 2016

“Liquid biopsies” for cancer screening: Life-saving tests, or overdiagnosis and overtreatment taken to a new level?

I’ve written many times about how the relationship between the early detection of cancer and decreased mortality from cancer is not nearly as straightforward as the average person—even the average doctor—thinks, the first time being in the very first year of this blog’s existence. Since then, the complexities and overpromising of various screening modalities designed to detect disease at an early, asymptomatic...

/ September 28, 2015

Screening for disease in people without symptoms: The reality

One of the most contentious questions that come up in science-based medicine that we discuss on this blog is the issue of screening asymptomatic individuals for disease. The most common conditions screened for that we, at least, have discussed on this blog are cancers (e.g., mammography for breast cancer, prostate-specific antigen screening for prostate cancer, ultrasound screening for thyroid cancer), but screening...

/ February 2, 2015